Literature DB >> 9225683

Accumulation of beta-amyloid precursor protein in HIV encephalitis: relationship with neuropsychological abnormalities.

B Giometto1, S F An, M Groves, T Scaravilli, J F Geddes, R Miller, B Tavolato, A A Beckett, F Scaravilli.   

Abstract

The pathogenesis of neuropsychological abnormalities in patients with human immunodeficiency virus type 1 (HIV-1) encephalitis is obscure because neurons are not the target of infection and severe neuronal loss occurs only late during the disease. Moreover, there is evidence indicating that HIV dementia is not a homogeneous entity and could partially reverse after treatment with zidovudine. The finding that impaired axonal flow, evidenced by beta-amyloid precursor protein immunoreactivity, could contribute to the neuropsychological deficits prompted the present study. Brains of patients with full-blown acquired immunodeficiency syndrome (AIDS) were studied and findings compared with those of normal and abnormal control subjects. The presence of HIV-1 DNA was investigated by nested polymerase chain reaction; axonal abnormalities were detected by beta-amyloid precursor protein, ubiquitin immunohistochemistry, and silver staining. Accumulation of beta-amyloid precursor protein was observed in all the HIV encephalitis brains studied; the appearance of the immunostaining varied from globular structures to bundles of parallel formations. In 2 AIDS brains without pathological abnormalities, only the latter pattern was detected. The brains with trauma were strongly reactive with beta-amyloid precursor protein antibody and the different reactivity within them correlated with posttrauma survival, only globular structures being detected in the older cases. No correlation was found between the different pattern of beta-amyloid precursor protein reactivity and dementia in AIDS patients. These results show that widespread axonal injury is a constant feature in AIDS brains and suggest that it could play a role in the pathogenesis of the neuropsychological abnormalities of these patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9225683     DOI: 10.1002/ana.410420108

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  32 in total

1.  Clinical contributors to cerebral white matter integrity in HIV-infected individuals.

Authors:  Assawin Gongvatana; Ronald A Cohen; Stephen Correia; Kathryn N Devlin; Jadrian Miles; Hakmook Kang; Hernando Ombao; Bradford Navia; David H Laidlaw; Karen T Tashima
Journal:  J Neurovirol       Date:  2011-10-01       Impact factor: 2.643

2.  HIV-1 gp120-induced axonal injury detected by accumulation of β-amyloid precursor protein in adult rat corpus callosum.

Authors:  Jingdong Zhang; Jianuo Liu; Bryan Katafiasz; Howard Fox; Huangui Xiong
Journal:  J Neuroimmune Pharmacol       Date:  2011-02-02       Impact factor: 4.147

3.  Immunodetection of human immunodeficiency virus type 1 (HIV-1) Vpr in brain tissue of HIV-1 encephalitic patients.

Authors:  Elizabeth D A Wheeler; Cristian L Achim; Velpandi Ayyavoo
Journal:  J Neurovirol       Date:  2006-06       Impact factor: 2.643

4.  Alterations in brain TREM2 and Amyloid-β levels are associated with neurocognitive impairment in HIV-infected persons on antiretroviral therapy.

Authors:  Jerel Adam Fields; Brian Spencer; Mary Swinton; Emma Martine Qvale; María J Marquine; Arina Alexeeva; Sarah Gough; Benchawanna Soontornniyomkij; Elvira Valera; Eliezer Masliah; Cristian L Achim; Paula Desplats
Journal:  J Neurochem       Date:  2018-11-26       Impact factor: 5.372

5.  Axonopathy in the Central Nervous System Is the Hallmark of Mice with a Novel Intragenic Null Mutation of Dystonin.

Authors:  Frauke Seehusen; Kirsten Kiel; Stefano Jottini; Peter Wohlsein; Andre Habierski; Katharina Seibel; Tanja Vogel; Henning Urlaub; Martin Kollmar; Wolfgang Baumgärtner; Ulrike Teichmann
Journal:  Genetics       Date:  2016-07-08       Impact factor: 4.562

Review 6.  Amyloid beta accumulation in HIV-1-infected brain: The role of the blood brain barrier.

Authors:  Ibolya E András; Michal Toborek
Journal:  IUBMB Life       Date:  2012-12-07       Impact factor: 3.885

7.  Increased accumulation of intraneuronal amyloid beta in HIV-infected patients.

Authors:  Cristian L Achim; Anthony Adame; Wilmar Dumaop; Ian P Everall; Eliezer Masliah
Journal:  J Neuroimmune Pharmacol       Date:  2009-03-17       Impact factor: 4.147

8.  HIV-1-induced amyloid beta accumulation in brain endothelial cells is attenuated by simvastatin.

Authors:  Ibolya E András; Sung Yong Eum; Wen Huang; Yu Zhong; Bernhard Hennig; Michal Toborek
Journal:  Mol Cell Neurosci       Date:  2009-11-26       Impact factor: 4.314

9.  Systemic and brain macrophage infections in relation to the development of simian immunodeficiency virus encephalitis.

Authors:  Stephanie J Bissel; Guoji Wang; Dafna Bonneh-Barkay; Adam Starkey; Anita M Trichel; Michael Murphey-Corb; Clayton A Wiley
Journal:  J Virol       Date:  2008-03-12       Impact factor: 5.103

10.  Synaptic proteins linked to HIV-1 infection and immunoproteasome induction: proteomic analysis of human synaptosomes.

Authors:  Benjamin B Gelman; Trung P Nguyen
Journal:  J Neuroimmune Pharmacol       Date:  2009-08-20       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.